
Cancer Drugs & Oncology Drugs
Prescription drugs for the medical, surgical, and radiation treatment of tumors (cancerous, especially). Studies in this area include most types of cancer and treatment thereof.
The list of FDA approved drugs for cancer and oncology appears below. Click any link to view the full drug information.
Number Of Cancer Drugs & Oncology Drugs: 148
For the treatment of non-small cell lung cancer
For the treatment of breakthrough cancer pain in opioid-tolerant patients
Treatment for Cancer Pain
For the treatment of Hodgkin lymphoma and anaplastic large cell lymphoma
For the treatment of renal cell carcinoma
For the treatment of renal angiomyolipoma associated with tuberous sclerosis complex
For the treatment of advanced pancreatic neuroendocrine tumors
For the treatment of hormone receptor-positive, HER2-negative breast cancer
For the treatment of malignant pleural mesothelioma
For the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy
Treatment for chronic pain
Treatment for emesis
Treatment for the prevention of nausea and vomiting associated with chemotherapy and surgery
Treatment for osteolytic bone metastases of breast cancer
Treatment for advanced breast cancer in postmenopausal women
Exemestane Tablets, 25 mg
For the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
For the treatment of chronic lymphocytic leukemia
For the treatment of renal cell carcinoma
For the treatment of metastatic carcinoma of the colon or rectum
For the treatment of patients with CD20 positive, follicular, non-Hodgkin's lymphoma following chemotherapy relapse
For the treatment of Ph+ chronic myelogenous leukemia
Management of acute pain
For use in combination for the treatment of leukemia
Injectable treatment of B-cell chronic lymphocytic leukemia
Treatment for metastatic colorectal cancer
Treatment for Colon or Rectal Cancer
Diagnostic imaging product for colorectal cancer
For the prevention of cervical cancer and cervical intraepithelial neoplasia caused by HPV types 16 and 18
For the treatment of acute lymphoblastic leukemia in pediatric patients
For the treatment of prostate cancer
Treatment for ovarian cancer that is refractory to other first-line therapies
For the palliative treatment of advanced prostate cancer
For the management of plasma uric acid levels in adults with malignancies
epirubicin hydrochloride
Treatment of meningeal leukemia or lymphocytic lymphoma
For the treatment of colon or rectum carcinomas
For the treatment of nausea and vomiting associated with chemotherapy
For the treatment of EGFR-expressing, metastatic colorectal cancer
For the treatment of basal cell carcinoma
For the treatment of acute lymphoblastic leukemia
Treatment to reduce renal toxicity associated with chemotherapy in subjects with advanced ovarian cancer
Treatment for xerostomia (dry mouth) due to radiation
Treatment for prostate cancer
For the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women
For the treatment of hormone receptor positive metastatic breast cancer
First-line treatment of postmenopausal women with locally advanced or metastatic breast cancer
Contrast agent for magnetic resonance imaging of liver lesions
For the treatment of peripheral T-cell lymphoma
For rescue after high-dose methotrexate therapy in osteosarcoma and to reduce the toxicity of methotrexate
For the prevention of cervical cancer associated with human papillomavirus
Contrast agent for magnetic resonance imaging of the gastrointestinal tract
Treatment for pancreatic cancer
Treatment for Lung Cancer
Oral therapy for the treatment of chronic myeloid leukemia
For the treatment of gastrointestinal stromal tumors (GISTs)
Treatment for brain cancer
For the treatment of metastatic breast cancer
Treatment for metastatic breast cancer
For the treatment of gastric cancer
Treatment for metastatic ovarian cancer
For the treatment of small cell lung cancer
Treatment for breast cancer prediction
For the treatment of advanced renal cell carcinoma
An adjuvant treatment to surgery in subjects at high risk for systemic recurrence of malignant melanoma
Treatment for non-Hodgkin's lymphoma
For the second-line treatment of non-small-cell lung cancer
For the treatment of cutaneous T-cell lymphoma
For the treatment of breast cancer
For the treatment of prostate cancer
Treatment for chronic moderate to severe pain
For the treatment of multiple myeloma
For the prevention of nausea and vomiting associated with cancer therapy
Prevention of nausea and vomiting associated with chemotherapy
For the management of breakthrough cancer pain
Treatment for mobilizing peripheral blood progenitor cells for use after transplantation.
Treatment for the replenishment of white blood cells
Treatment for prostate cancer
For the treatment of Ph- acute lymphoblastic leukemia
Test for breast cancer
For the treatment of non-Hodgkin?s lymphoma and multiple myeloma
For the treatment of CD33 positive acute myeloid leukemia (AML)
Treatment to decrease the chance of infection by febrile neutropenia in patients receiving chemotherapy
Treatment for thrombocytopenia
Treatment for slow white blood cell recovery following chemotherapy
For the reduction in the duration of severe chemotherapy-induced neutropenia
For the Treatment of Renal Cell Carcinoma
Treatment for Breast Cancer
For the management of breakthrough cancer pain
For the first-line treatment of HER2+ metastatic breast cancer
Photodynamic therapy device for the treatment of esophageal cancer
Treatment for early-stage, microinvasive endobronchial non-small cell lung cancer
For the treatment of actinic keratosis
For treatment of advanced prostate cancer
For the prevention of postmenopausal osteoporosis and treatment of vasomotor menopause symptoms
Treatment for metastatic melanoma
For the treatment of hormone refractory prostate cancer
Treatment for pain associated with bone cancer
Treatment for non-hodgkin's lymphoma
For the treatment of chemotherapy-induced nausea and vomiting
Treatment for malignant pleural effusions
To aid in the diagnosis of pancreatic dysfunction and gastrinoma
Self-examination breast pad
For the treatment of secondary hyperparathyroidism and hypercalcemia in parathyroid carcinoma patients
For the treatment of imatinib-resistant chronic myeloid leukemia
For the treatment of previously treated patients with metastatic colorectal cancer
For the treatment of breakthrough cancer pain
For the treatment of pancreatic neuroendocrine tumors
For the treatment of kidney cancer and gastrointestinal stromal tumors
For the treatment of melanoma
For the treatment of advanced refractory metastatic non-small cell lung cancer
For the treatment of chronic myelogenous leukemia
Treatment for AIDS-related Kaposi's Sarcoma
Treatment for locally advanced or metastatic breast cancer
Treatment for refractory anaplastic astrocytoma
For the treatment of renal cell carcinoma
For the treatment of Chronic lymphocytic leukemia and B-cell non-Hodgkin?s lymphoma
For the palliative treatment of advanced prostate cancer
Intramuscular injection for the treatment of advanced stage prostate cancer
For the induction of remission and consolidation in patients with acute promyelocytic leukemia (APL)
For the treatment of breast cancer
Treatment for chronic pain
For the treatment of of the signs and symptoms of benign prostatic hyperplasia
Treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL)
Treatment for Bladder Cancer
For the treatment of thyroid cancer
For the treatment of colorectal cancer
Injectable agent for the treatment of multiple myeloma patients who have received at least two prior therapies.
For pain relief in men with advanced prostate cancer
Diagnostic contrast agent
For the treatment of renal cell carcinoma
For the treatment of soft tissue sarcoma
For the treatment of ALK+ non-small cell lung cancer
Oral chemotherapy for the treatment of metastatic colorectal cancer
Treatment for advanced breast cancer tumors
For the prevention of skeletal-related events in patients with bone metastases from solid tumors
For the treatment of metastatic castration-resistant prostate cancer
For the treatment of metastatic melanoma
For the treatment of metastatic colorectal cancer
For the treatment of BRAF + melanoma
For the treatment of non-Hodgkin's lymphoma
Treatment for postoperative vomiting and nausea in adults
Treatment for the prevention of chemotherapy and radiation-induced nausea
Treatment for advanced prostate cancer
For the treatment of hypercalcemia of malignancy
For the treatment of multiple myeloma and bone metastases from solid tumors
For the prevention of post-operative, chemotherapy and radiotherapy induced nausea and vomiting
For the treatment of prostate cancer
FDA Approved Cancer Drugs & Oncology Drugs Listings:
The rules of principle for evaluating MediLexicon's FDA cancer drugs & oncology drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The cancer drugs & oncology drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.



